Correlation Between Vericel Corp and Brainstorm Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and Brainstorm Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and Brainstorm Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and Brainstorm Cell Therapeutics, you can compare the effects of market volatilities on Vericel Corp and Brainstorm Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of Brainstorm Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and Brainstorm Cell.

Diversification Opportunities for Vericel Corp and Brainstorm Cell

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Vericel and Brainstorm is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and Brainstorm Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainstorm Cell Ther and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with Brainstorm Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainstorm Cell Ther has no effect on the direction of Vericel Corp i.e., Vericel Corp and Brainstorm Cell go up and down completely randomly.

Pair Corralation between Vericel Corp and Brainstorm Cell

Given the investment horizon of 90 days Vericel Corp Ord is expected to under-perform the Brainstorm Cell. But the stock apears to be less risky and, when comparing its historical volatility, Vericel Corp Ord is 3.03 times less risky than Brainstorm Cell. The stock trades about -0.09 of its potential returns per unit of risk. The Brainstorm Cell Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  171.00  in Brainstorm Cell Therapeutics on December 2, 2024 and sell it today you would lose (11.00) from holding Brainstorm Cell Therapeutics or give up 6.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vericel Corp Ord  vs.  Brainstorm Cell Therapeutics

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vericel Corp Ord has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's technical and fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Brainstorm Cell Ther 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Brainstorm Cell Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong essential indicators, Brainstorm Cell is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Vericel Corp and Brainstorm Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and Brainstorm Cell

The main advantage of trading using opposite Vericel Corp and Brainstorm Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, Brainstorm Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will offset losses from the drop in Brainstorm Cell's long position.
The idea behind Vericel Corp Ord and Brainstorm Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.